Big Pharma-backed Atalanta Therapeutics is ramping up for the clinical debut of the company’s lead epilepsy asset in the wake ...

Welcome to CureVac fourth-quarter and full year 2024 financial results and business update call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to ...

The three wolves – named Romulus, Remus and Khaleesi – live in a private facility and have reportedly grown as big as 80 ...

Investigators from Mass General Brigham and Beth Israel Deaconess Medical Center have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

Gain access to over 25 informative sessions and presentations on truck productivity, decarbonisation, workforce inclusion, ...

President Trump’s newly announced tariff policy has done more than just push the stock markets deeper into correction territory — the sudden ...

Karl Koehler builds inner ear and skin organoids from human stem cells to model their development in health and disease.

Investigators from Mass General Brigham and Beth Israel Deaconess Medical Center have developed STITCHR, a new gene editing tool that can insert ...

Immunizing mice with an edited Lyme disease-causing bacterial protein effectively protected them against the disease.

This breakthrough is expected to boost local conservation efforts There used to be a time when the primarily nocturnal Visayan spotted deer (Rusa alfredi) could be found in large numbers across inland ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...